Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19
Long-COVID refers to a variety of symptoms affecting different organs reported by people following Coronavirus Disease 2019 (COVID-19) infection. To date, there have been no robust estimates of the incidence and co-occurrence of long-COVID features, their relationship to age, sex, or severity of inf...
Saved in:
| Published in | PLoS medicine Vol. 18; no. 9; p. e1003773 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
San Francisco
Public Library of Science
28.09.2021
Public Library of Science (PLoS) |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Long-COVID refers to a variety of symptoms affecting different organs reported by people following Coronavirus Disease 2019 (COVID-19) infection. To date, there have been no robust estimates of the incidence and co-occurrence of long-COVID features, their relationship to age, sex, or severity of infection, and the extent to which they are specific to COVID-19. The aim of this study is to address these issues. We conducted a retrospective cohort study based on linked electronic health records (EHRs) data from 81 million patients including 273,618 COVID-19 survivors. The incidence and co-occurrence within 6 months and in the 3 to 6 months after COVID-19 diagnosis were calculated for 9 core features of long-COVID (breathing difficulties/breathlessness, fatigue/malaise, chest/throat pain, headache, abdominal symptoms, myalgia, other pain, cognitive symptoms, and anxiety/depression). Their co-occurrence network was also analyzed. Comparison with a propensity score-matched cohort of patients diagnosed with influenza during the same time period was achieved using Kaplan-Meier analysis and the Cox proportional hazard model. The incidence of atopic dermatitis was used as a negative control. Long-COVID clinical features occurred and co-occurred frequently and showed some specificity to COVID-19, though they were also observed after influenza. Different long-COVID clinical profiles were observed based on demographics and illness severity. |
|---|---|
| AbstractList | Background Long-COVID refers to a variety of symptoms affecting different organs reported by people following Coronavirus Disease 2019 (COVID-19) infection. To date, there have been no robust estimates of the incidence and co-occurrence of long-COVID features, their relationship to age, sex, or severity of infection, and the extent to which they are specific to COVID-19. The aim of this study is to address these issues. Methods and findings We conducted a retrospective cohort study based on linked electronic health records (EHRs) data from 81 million patients including 273,618 COVID-19 survivors. The incidence and co-occurrence within 6 months and in the 3 to 6 months after COVID-19 diagnosis were calculated for 9 core features of long-COVID (breathing difficulties/breathlessness, fatigue/malaise, chest/throat pain, headache, abdominal symptoms, myalgia, other pain, cognitive symptoms, and anxiety/depression). Their co-occurrence network was also analyzed. Comparison with a propensity score–matched cohort of patients diagnosed with influenza during the same time period was achieved using Kaplan–Meier analysis and the Cox proportional hazard model. The incidence of atopic dermatitis was used as a negative control. Among COVID-19 survivors (mean [SD] age: 46.3 [19.8], 55.6% female), 57.00% had one or more long-COVID feature recorded during the whole 6-month period (i.e., including the acute phase), and 36.55% between 3 and 6 months. The incidence of each feature was: abnormal breathing (18.71% in the 1- to 180-day period; 7.94% in the 90- to180-day period), fatigue/malaise (12.82%; 5.87%), chest/throat pain (12.60%; 5.71%), headache (8.67%; 4.63%), other pain (11.60%; 7.19%), abdominal symptoms (15.58%; 8.29%), myalgia (3.24%; 1.54%), cognitive symptoms (7.88%; 3.95%), and anxiety/depression (22.82%; 15.49%). All 9 features were more frequently reported after COVID-19 than after influenza (with an overall excess incidence of 16.60% and hazard ratios between 1.44 and 2.04, all p < 0.001), co-occurred more commonly, and formed a more interconnected network. Significant differences in incidence and co-occurrence were associated with sex, age, and illness severity. Besides the limitations inherent to EHR data, limitations of this study include that (i) the findings do not generalize to patients who have had COVID-19 but were not diagnosed, nor to patients who do not seek or receive medical attention when experiencing symptoms of long-COVID; (ii) the findings say nothing about the persistence of the clinical features; and (iii) the difference between cohorts might be affected by one cohort seeking or receiving more medical attention for their symptoms. Conclusions Long-COVID clinical features occurred and co-occurred frequently and showed some specificity to COVID-19, though they were also observed after influenza. Different long-COVID clinical profiles were observed based on demographics and illness severity. Long-COVID refers to a variety of symptoms affecting different organs reported by people following Coronavirus Disease 2019 (COVID-19) infection. To date, there have been no robust estimates of the incidence and co-occurrence of long-COVID features, their relationship to age, sex, or severity of infection, and the extent to which they are specific to COVID-19. The aim of this study is to address these issues. We conducted a retrospective cohort study based on linked electronic health records (EHRs) data from 81 million patients including 273,618 COVID-19 survivors. The incidence and co-occurrence within 6 months and in the 3 to 6 months after COVID-19 diagnosis were calculated for 9 core features of long-COVID (breathing difficulties/breathlessness, fatigue/malaise, chest/throat pain, headache, abdominal symptoms, myalgia, other pain, cognitive symptoms, and anxiety/depression). Their co-occurrence network was also analyzed. Comparison with a propensity score-matched cohort of patients diagnosed with influenza during the same time period was achieved using Kaplan-Meier analysis and the Cox proportional hazard model. The incidence of atopic dermatitis was used as a negative control. Long-COVID clinical features occurred and co-occurred frequently and showed some specificity to COVID-19, though they were also observed after influenza. Different long-COVID clinical profiles were observed based on demographics and illness severity. Long-COVID refers to a variety of symptoms affecting different organs reported by people following Coronavirus Disease 2019 (COVID-19) infection. To date, there have been no robust estimates of the incidence and co-occurrence of long-COVID features, their relationship to age, sex, or severity of infection, and the extent to which they are specific to COVID-19. The aim of this study is to address these issues.BACKGROUNDLong-COVID refers to a variety of symptoms affecting different organs reported by people following Coronavirus Disease 2019 (COVID-19) infection. To date, there have been no robust estimates of the incidence and co-occurrence of long-COVID features, their relationship to age, sex, or severity of infection, and the extent to which they are specific to COVID-19. The aim of this study is to address these issues.We conducted a retrospective cohort study based on linked electronic health records (EHRs) data from 81 million patients including 273,618 COVID-19 survivors. The incidence and co-occurrence within 6 months and in the 3 to 6 months after COVID-19 diagnosis were calculated for 9 core features of long-COVID (breathing difficulties/breathlessness, fatigue/malaise, chest/throat pain, headache, abdominal symptoms, myalgia, other pain, cognitive symptoms, and anxiety/depression). Their co-occurrence network was also analyzed. Comparison with a propensity score-matched cohort of patients diagnosed with influenza during the same time period was achieved using Kaplan-Meier analysis and the Cox proportional hazard model. The incidence of atopic dermatitis was used as a negative control. Among COVID-19 survivors (mean [SD] age: 46.3 [19.8], 55.6% female), 57.00% had one or more long-COVID feature recorded during the whole 6-month period (i.e., including the acute phase), and 36.55% between 3 and 6 months. The incidence of each feature was: abnormal breathing (18.71% in the 1- to 180-day period; 7.94% in the 90- to180-day period), fatigue/malaise (12.82%; 5.87%), chest/throat pain (12.60%; 5.71%), headache (8.67%; 4.63%), other pain (11.60%; 7.19%), abdominal symptoms (15.58%; 8.29%), myalgia (3.24%; 1.54%), cognitive symptoms (7.88%; 3.95%), and anxiety/depression (22.82%; 15.49%). All 9 features were more frequently reported after COVID-19 than after influenza (with an overall excess incidence of 16.60% and hazard ratios between 1.44 and 2.04, all p < 0.001), co-occurred more commonly, and formed a more interconnected network. Significant differences in incidence and co-occurrence were associated with sex, age, and illness severity. Besides the limitations inherent to EHR data, limitations of this study include that (i) the findings do not generalize to patients who have had COVID-19 but were not diagnosed, nor to patients who do not seek or receive medical attention when experiencing symptoms of long-COVID; (ii) the findings say nothing about the persistence of the clinical features; and (iii) the difference between cohorts might be affected by one cohort seeking or receiving more medical attention for their symptoms.METHODS AND FINDINGSWe conducted a retrospective cohort study based on linked electronic health records (EHRs) data from 81 million patients including 273,618 COVID-19 survivors. The incidence and co-occurrence within 6 months and in the 3 to 6 months after COVID-19 diagnosis were calculated for 9 core features of long-COVID (breathing difficulties/breathlessness, fatigue/malaise, chest/throat pain, headache, abdominal symptoms, myalgia, other pain, cognitive symptoms, and anxiety/depression). Their co-occurrence network was also analyzed. Comparison with a propensity score-matched cohort of patients diagnosed with influenza during the same time period was achieved using Kaplan-Meier analysis and the Cox proportional hazard model. The incidence of atopic dermatitis was used as a negative control. Among COVID-19 survivors (mean [SD] age: 46.3 [19.8], 55.6% female), 57.00% had one or more long-COVID feature recorded during the whole 6-month period (i.e., including the acute phase), and 36.55% between 3 and 6 months. The incidence of each feature was: abnormal breathing (18.71% in the 1- to 180-day period; 7.94% in the 90- to180-day period), fatigue/malaise (12.82%; 5.87%), chest/throat pain (12.60%; 5.71%), headache (8.67%; 4.63%), other pain (11.60%; 7.19%), abdominal symptoms (15.58%; 8.29%), myalgia (3.24%; 1.54%), cognitive symptoms (7.88%; 3.95%), and anxiety/depression (22.82%; 15.49%). All 9 features were more frequently reported after COVID-19 than after influenza (with an overall excess incidence of 16.60% and hazard ratios between 1.44 and 2.04, all p < 0.001), co-occurred more commonly, and formed a more interconnected network. Significant differences in incidence and co-occurrence were associated with sex, age, and illness severity. Besides the limitations inherent to EHR data, limitations of this study include that (i) the findings do not generalize to patients who have had COVID-19 but were not diagnosed, nor to patients who do not seek or receive medical attention when experiencing symptoms of long-COVID; (ii) the findings say nothing about the persistence of the clinical features; and (iii) the difference between cohorts might be affected by one cohort seeking or receiving more medical attention for their symptoms.Long-COVID clinical features occurred and co-occurred frequently and showed some specificity to COVID-19, though they were also observed after influenza. Different long-COVID clinical profiles were observed based on demographics and illness severity.CONCLUSIONSLong-COVID clinical features occurred and co-occurred frequently and showed some specificity to COVID-19, though they were also observed after influenza. Different long-COVID clinical profiles were observed based on demographics and illness severity. BackgroundLong-COVID refers to a variety of symptoms affecting different organs reported by people following Coronavirus Disease 2019 (COVID-19) infection. To date, there have been no robust estimates of the incidence and co-occurrence of long-COVID features, their relationship to age, sex, or severity of infection, and the extent to which they are specific to COVID-19. The aim of this study is to address these issues.Methods and findingsWe conducted a retrospective cohort study based on linked electronic health records (EHRs) data from 81 million patients including 273,618 COVID-19 survivors. The incidence and co-occurrence within 6 months and in the 3 to 6 months after COVID-19 diagnosis were calculated for 9 core features of long-COVID (breathing difficulties/breathlessness, fatigue/malaise, chest/throat pain, headache, abdominal symptoms, myalgia, other pain, cognitive symptoms, and anxiety/depression). Their co-occurrence network was also analyzed. Comparison with a propensity score-matched cohort of patients diagnosed with influenza during the same time period was achieved using Kaplan-Meier analysis and the Cox proportional hazard model. The incidence of atopic dermatitis was used as a negative control. Among COVID-19 survivors (mean [SD] age: 46.3 [19.8], 55.6% female), 57.00% had one or more long-COVID feature recorded during the whole 6-month period (i.e., including the acute phase), and 36.55% between 3 and 6 months. The incidence of each feature was: abnormal breathing (18.71% in the 1- to 180-day period; 7.94% in the 90- to180-day period), fatigue/malaise (12.82%; 5.87%), chest/throat pain (12.60%; 5.71%), headache (8.67%; 4.63%), other pain (11.60%; 7.19%), abdominal symptoms (15.58%; 8.29%), myalgia (3.24%; 1.54%), cognitive symptoms (7.88%; 3.95%), and anxiety/depression (22.82%; 15.49%). All 9 features were more frequently reported after COVID-19 than after influenza (with an overall excess incidence of 16.60% and hazard ratios between 1.44 and 2.04, all p < 0.001), co-occurred more commonly, and formed a more interconnected network. Significant differences in incidence and co-occurrence were associated with sex, age, and illness severity. Besides the limitations inherent to EHR data, limitations of this study include that (i) the findings do not generalize to patients who have had COVID-19 but were not diagnosed, nor to patients who do not seek or receive medical attention when experiencing symptoms of long-COVID; (ii) the findings say nothing about the persistence of the clinical features; and (iii) the difference between cohorts might be affected by one cohort seeking or receiving more medical attention for their symptoms.ConclusionsLong-COVID clinical features occurred and co-occurred frequently and showed some specificity to COVID-19, though they were also observed after influenza. Different long-COVID clinical profiles were observed based on demographics and illness severity. Background Long-COVID refers to a variety of symptoms affecting different organs reported by people following Coronavirus Disease 2019 (COVID-19) infection. To date, there have been no robust estimates of the incidence and co-occurrence of long-COVID features, their relationship to age, sex, or severity of infection, and the extent to which they are specific to COVID-19. The aim of this study is to address these issues. Methods and findings We conducted a retrospective cohort study based on linked electronic health records (EHRs) data from 81 million patients including 273,618 COVID-19 survivors. The incidence and co-occurrence within 6 months and in the 3 to 6 months after COVID-19 diagnosis were calculated for 9 core features of long-COVID (breathing difficulties/breathlessness, fatigue/malaise, chest/throat pain, headache, abdominal symptoms, myalgia, other pain, cognitive symptoms, and anxiety/depression). Their co-occurrence network was also analyzed. Comparison with a propensity score–matched cohort of patients diagnosed with influenza during the same time period was achieved using Kaplan–Meier analysis and the Cox proportional hazard model. The incidence of atopic dermatitis was used as a negative control. Among COVID-19 survivors (mean [SD] age: 46.3 [19.8], 55.6% female), 57.00% had one or more long-COVID feature recorded during the whole 6-month period (i.e., including the acute phase), and 36.55% between 3 and 6 months. The incidence of each feature was: abnormal breathing (18.71% in the 1- to 180-day period; 7.94% in the 90- to180-day period), fatigue/malaise (12.82%; 5.87%), chest/throat pain (12.60%; 5.71%), headache (8.67%; 4.63%), other pain (11.60%; 7.19%), abdominal symptoms (15.58%; 8.29%), myalgia (3.24%; 1.54%), cognitive symptoms (7.88%; 3.95%), and anxiety/depression (22.82%; 15.49%). All 9 features were more frequently reported after COVID-19 than after influenza (with an overall excess incidence of 16.60% and hazard ratios between 1.44 and 2.04, all p < 0.001), co-occurred more commonly, and formed a more interconnected network. Significant differences in incidence and co-occurrence were associated with sex, age, and illness severity. Besides the limitations inherent to EHR data, limitations of this study include that (i) the findings do not generalize to patients who have had COVID-19 but were not diagnosed, nor to patients who do not seek or receive medical attention when experiencing symptoms of long-COVID; (ii) the findings say nothing about the persistence of the clinical features; and (iii) the difference between cohorts might be affected by one cohort seeking or receiving more medical attention for their symptoms. Conclusions Long-COVID clinical features occurred and co-occurred frequently and showed some specificity to COVID-19, though they were also observed after influenza. Different long-COVID clinical profiles were observed based on demographics and illness severity. Maxime Taquet and colleagues investigate the incidence, co-occurrence and evolution of long-COVID features in more than a quarter of a million people. |
| Audience | Academic |
| Author | Luciano, Sierra Geddes, John R. Harrison, Paul J. Taquet, Maxime Dercon, Quentin Husain, Masud |
| AuthorAffiliation | 1 Department of Psychiatry, University of Oxford, United Kingdom 4 Nuffield Department of Clinical Neurosciences, University of Oxford, United Kingdom 5 Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom Universitair Medisch Centrum Utrecht, NETHERLANDS 2 Oxford Health NHS Foundation Trust, Oxford, United Kingdom 3 TriNetX Inc., Cambridge, Massachusetts, United States of America |
| AuthorAffiliation_xml | – name: 1 Department of Psychiatry, University of Oxford, United Kingdom – name: 4 Nuffield Department of Clinical Neurosciences, University of Oxford, United Kingdom – name: 3 TriNetX Inc., Cambridge, Massachusetts, United States of America – name: Universitair Medisch Centrum Utrecht, NETHERLANDS – name: 5 Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom – name: 2 Oxford Health NHS Foundation Trust, Oxford, United Kingdom |
| Author_xml | – sequence: 1 givenname: Maxime orcidid: 0000-0002-8987-952X surname: Taquet fullname: Taquet, Maxime – sequence: 2 givenname: Quentin orcidid: 0000-0001-8264-347X surname: Dercon fullname: Dercon, Quentin – sequence: 3 givenname: Sierra surname: Luciano fullname: Luciano, Sierra – sequence: 4 givenname: John R. surname: Geddes fullname: Geddes, John R. – sequence: 5 givenname: Masud orcidid: 0000-0002-6850-9255 surname: Husain fullname: Husain, Masud – sequence: 6 givenname: Paul J. surname: Harrison fullname: Harrison, Paul J. |
| BookMark | eNqVk-tq2zAUx83oWC_bGwxmGIwN6kyyZUvuh0HoboGywC79KmT52FFwpEySw_oAe-_JjQt1CWPDYEvHv_PX0bmcRkfaaIii5xjNcEbx27XprRbdbLuBeoYRyijNHkUnOCdlggtaHN1bH0enzq0RSktUoifRcUZylhKCT6LfCy1VDVrCeSxNYqTsrd1vha5j2Jmu98ro2DRxZ3SbXC6vF-_jBoTvLbiLeB4XycZov4oteGvcFqRXOwhiK2N97Hxf3wzOKc3OC8xi19ud2hnrBuOtWILLp9HjRnQOno3fs-jHxw_fLz8nV8tPi8v5VSIZoj6hZZUywFUKOamrCvImvEUqSpB1JgqMUd5ICUWaU9xUFQ17KSUCDJgWVEJ2Fr3Y62474_iYQcfTkI2clTktArHYE7URa761aiPsDTdC8VuDsS0X1ivZAW_ytCzrhgmMKanrghEkSsaKoqEUhTiC1rvxtL4KRZKgvRXdRHT6R6sVb82OM0JZikkQeD0KWPOzB-f5RjkJXSc0mH6Im4aiI0LSgL58gB6-3Ui1IlxA6caEc-UgyucFpSXLaY4DlRygWtAQggxN2KhgnvCzA3x4atgoedDhzcQhMB5--Vb0zvHFt6__wX75d3Z5PWVf3WNXIDq_cmOzuyl4sQdl6G5noeFSeTFg4Zaq4xjxYR7v8s2HeeTjPAZn8sD5rvp_dfsDNJc4oQ |
| CitedBy_id | crossref_primary_10_4103_ijph_ijph_1178_22 crossref_primary_10_1136_bmjopen_2022_067611 crossref_primary_10_1016_j_jaip_2023_05_029 crossref_primary_10_1093_ageing_afad204 crossref_primary_10_1177_23337214221094192 crossref_primary_10_1186_s12879_022_07639_1 crossref_primary_10_1007_s11357_024_01227_8 crossref_primary_10_4103_ijrc_ijrc_16_22 crossref_primary_10_1016_j_pec_2024_108180 crossref_primary_10_1186_s40478_021_01302_7 crossref_primary_10_1038_s41598_022_24307_1 crossref_primary_10_1038_s41467_023_37368_1 crossref_primary_10_3389_fpsyt_2022_947583 crossref_primary_10_3389_fimmu_2022_920627 crossref_primary_10_1089_whr_2024_0131 crossref_primary_10_1111_papr_13277 crossref_primary_10_3390_jcm11164787 crossref_primary_10_1007_s11357_024_01096_1 crossref_primary_10_1016_j_cell_2022_01_014 crossref_primary_10_1159_000540919 crossref_primary_10_1371_journal_pone_0269353 crossref_primary_10_1128_spectrum_01386_22 crossref_primary_10_1371_journal_pone_0278057 crossref_primary_10_1016_S2215_0366_24_00214_1 crossref_primary_10_7554_eLife_81090 crossref_primary_10_2196_44155 crossref_primary_10_1038_s41598_023_42321_9 crossref_primary_10_1097_j_pain_0000000000003129 crossref_primary_10_2139_ssrn_4112899 crossref_primary_10_1002_npr2_12495 crossref_primary_10_1017_erm_2024_32 crossref_primary_10_1007_s00405_022_07689_w crossref_primary_10_1136_bcr_2022_250191 crossref_primary_10_3390_children11030335 crossref_primary_10_1016_j_jns_2023_120827 crossref_primary_10_1371_journal_pmed_1004122 crossref_primary_10_3389_fpubh_2023_1175444 crossref_primary_10_3390_diseases12050095 crossref_primary_10_1186_s12967_023_04636_z crossref_primary_10_1001_jamanetworkopen_2023_7455 crossref_primary_10_1007_s00705_023_05801_x crossref_primary_10_1016_j_clinph_2023_01_010 crossref_primary_10_3390_jpm13071060 crossref_primary_10_1136_bmjopen_2021_055205 crossref_primary_10_1089_brain_2022_0058 crossref_primary_10_3390_ijerph191811421 crossref_primary_10_1038_s41467_021_26513_3 crossref_primary_10_1016_j_matbio_2023_02_001 crossref_primary_10_3390_ijerph192114392 crossref_primary_10_1371_journal_pone_0282451 crossref_primary_10_1038_s41380_024_02554_0 crossref_primary_10_7326_M21_4905 crossref_primary_10_1515_mr_2024_0013 crossref_primary_10_1080_10408398_2022_2143476 crossref_primary_10_1111_ijd_17196 crossref_primary_10_1371_journal_pone_0294780 crossref_primary_10_1097_COH_0000000000000789 crossref_primary_10_1016_j_cgh_2023_01_029 crossref_primary_10_1186_s12916_023_03200_2 crossref_primary_10_1097_PXT_0000000000000019 crossref_primary_10_1016_j_jns_2022_120487 crossref_primary_10_1089_neur_2023_0067 crossref_primary_10_1038_s41598_023_35058_y crossref_primary_10_1016_j_bbi_2023_01_010 crossref_primary_10_1016_S0140_6736_22_01214_4 crossref_primary_10_1038_s41590_024_01868_z crossref_primary_10_12688_wellcomeopenres_21766_1 crossref_primary_10_2147_JPR_S365026 crossref_primary_10_1113_EP090802 crossref_primary_10_1186_s12889_024_20925_8 crossref_primary_10_1186_s12916_023_03234_6 crossref_primary_10_9778_cmajo_20220077 crossref_primary_10_1016_j_bbih_2023_100708 crossref_primary_10_1089_jicm_2022_0700 crossref_primary_10_1089_jicm_2022_0821 crossref_primary_10_1126_scitranslmed_abq3059 crossref_primary_10_1016_j_ajp_2022_103438 crossref_primary_10_1016_j_virusres_2022_198882 crossref_primary_10_1212_NXI_0000000000200227 crossref_primary_10_1016_j_lansea_2024_100395 crossref_primary_10_1001_jamanetworkopen_2022_36057 crossref_primary_10_1055_a_2171_9349 crossref_primary_10_1016_j_bbih_2023_100720 crossref_primary_10_1146_annurev_med_043021_030635 crossref_primary_10_1371_journal_pone_0305835 crossref_primary_10_4178_epih_e2023079 crossref_primary_10_1016_j_intimp_2024_112673 crossref_primary_10_2196_39849 crossref_primary_10_1136_bmjresp_2022_001254 crossref_primary_10_1371_journal_pone_0289382 crossref_primary_10_1016_j_eclinm_2022_101483 crossref_primary_10_1111_hex_13603 crossref_primary_10_1016_j_clim_2023_109634 crossref_primary_10_1038_s41467_023_37653_z crossref_primary_10_1186_s12888_024_05899_6 crossref_primary_10_1111_jrh_12655 crossref_primary_10_1016_j_aprim_2023_102813 crossref_primary_10_1016_j_cegh_2024_101828 crossref_primary_10_1016_j_jpsychires_2025_02_005 crossref_primary_10_1016_j_bbi_2021_12_007 crossref_primary_10_1016_j_jbi_2025_104778 crossref_primary_10_3201_eid2909_221265 crossref_primary_10_1126_sciadv_adi9379 crossref_primary_10_5812_mejrh_142260 crossref_primary_10_1161_CIRCRESAHA_122_320825 crossref_primary_10_2196_51820 crossref_primary_10_2147_PHMT_S359333 crossref_primary_10_1007_s10238_023_01153_7 crossref_primary_10_2106_JBJS_RVW_22_00088 crossref_primary_10_2139_ssrn_4135323 crossref_primary_10_3390_healthcare10122577 crossref_primary_10_1038_s41386_024_01995_z crossref_primary_10_4103_1673_5374_382989 crossref_primary_10_1186_s12931_022_02173_9 crossref_primary_10_1038_s41591_022_02001_z crossref_primary_10_1097_j_pain_0000000000003110 crossref_primary_10_2147_PRBM_S461742 crossref_primary_10_1016_j_puhe_2024_10_016 crossref_primary_10_1097_MS9_0000000000000203 crossref_primary_10_1371_journal_pone_0292672 crossref_primary_10_1371_journal_pmed_1004052 crossref_primary_10_3390_ijms24129873 crossref_primary_10_1038_s41467_022_29513_z crossref_primary_10_31083_j_jin2103077 crossref_primary_10_3389_fpsyg_2024_1396963 crossref_primary_10_1016_j_csbj_2023_12_045 crossref_primary_10_1038_s41579_023_01001_1 crossref_primary_10_1080_23744235_2023_2175904 crossref_primary_10_1017_S0033291724002721 crossref_primary_10_1002_prca_202200031 crossref_primary_10_7759_cureus_42637 crossref_primary_10_1136_bmjopen_2023_076992 crossref_primary_10_3390_microorganisms11030713 crossref_primary_10_1097_JOM_0000000000003018 crossref_primary_10_3390_oral3010008 crossref_primary_10_3390_cancers15041269 crossref_primary_10_3390_brainsci14080744 crossref_primary_10_53065_kaznmu_2024_70_3_002 crossref_primary_10_1016_j_amjmed_2024_04_017 crossref_primary_10_1371_journal_pone_0280343 crossref_primary_10_1192_bjp_2024_97 crossref_primary_10_1111_1751_2980_13195 crossref_primary_10_1093_aje_kwad095 crossref_primary_10_1377_hlthaff_2022_00991 crossref_primary_10_3390_jpm11111234 crossref_primary_10_3238_arztebl_m2022_0231 crossref_primary_10_1038_s41591_022_01909_w crossref_primary_10_1111_jocn_16664 crossref_primary_10_3138_jammi_2022_0022 crossref_primary_10_1038_s41591_022_01840_0 crossref_primary_10_1093_cid_ciad143 crossref_primary_10_1155_2022_3431014 crossref_primary_10_1093_cid_ciac054 crossref_primary_10_1016_j_envadv_2023_100352 crossref_primary_10_1108_IJWHM_03_2021_0075 crossref_primary_10_1111_imj_15670 crossref_primary_10_1136_bmj_2021_068993 crossref_primary_10_1093_infdis_jiac474 crossref_primary_10_1097_MD_0000000000037311 crossref_primary_10_1016_j_smim_2023_101778 crossref_primary_10_1111_acel_14409 crossref_primary_10_1590_1983_1447_2024_20230283_pt crossref_primary_10_1007_s41974_023_00250_5 crossref_primary_10_3390_ijms23158606 crossref_primary_10_1186_s40814_022_01151_8 crossref_primary_10_1165_rcmb_2023_0167ED crossref_primary_10_3390_neurolint16040064 crossref_primary_10_1007_s10072_024_07620_7 crossref_primary_10_3389_fimmu_2023_1243689 crossref_primary_10_1212_WNL_0000000000208113 crossref_primary_10_3390_informatics11020041 crossref_primary_10_1080_1040841X_2023_2190405 crossref_primary_10_1371_journal_pmed_1004195 crossref_primary_10_3390_jcm11247314 crossref_primary_10_1177_10519815251319233 crossref_primary_10_3389_fcimb_2024_1396263 crossref_primary_10_2139_ssrn_4020142 crossref_primary_10_1016_j_amjms_2023_04_018 crossref_primary_10_1371_journal_pone_0312351 crossref_primary_10_3389_fpubh_2024_1106578 crossref_primary_10_2196_45767 crossref_primary_10_1016_j_jiph_2022_04_005 crossref_primary_10_1136_bmjopen_2022_064979 crossref_primary_10_1038_s41598_022_15727_0 crossref_primary_10_26416_Med_147_3_2022_6450 crossref_primary_10_3390_ijerph20054049 crossref_primary_10_3390_ijerph20156513 crossref_primary_10_3390_microorganisms11102458 crossref_primary_10_3390_ijerph192013003 crossref_primary_10_1038_s41398_024_02967_z crossref_primary_10_3389_fpubh_2024_1401734 crossref_primary_10_1007_s10787_024_01576_y crossref_primary_10_1007_s00415_022_11444_w crossref_primary_10_1136_bmjopen_2023_082314 crossref_primary_10_1016_j_ijid_2022_05_050 crossref_primary_10_1016_j_arbres_2022_03_006 crossref_primary_10_1093_braincomms_fcad357 crossref_primary_10_1186_s12879_023_08820_w crossref_primary_10_1002_rmv_2430 crossref_primary_10_1136_jnnp_2021_328516 crossref_primary_10_1371_journal_pone_0289245 crossref_primary_10_3389_fimmu_2024_1341843 crossref_primary_10_3389_fneur_2024_1465787 crossref_primary_10_14489_lcmp_2022_03_pp_057_064 crossref_primary_10_1371_journal_pone_0288391 crossref_primary_10_1530_EJE_22_0736 crossref_primary_10_1001_jamainternmed_2022_0424 crossref_primary_10_1186_s12916_022_02448_4 crossref_primary_10_1001_jamapediatrics_2022_2800 crossref_primary_10_1016_j_eclinm_2023_102251 crossref_primary_10_1016_j_accpm_2023_101267 crossref_primary_10_1007_s00127_023_02548_3 crossref_primary_10_36425_rehab121733 crossref_primary_10_1093_qjmed_hcac070 crossref_primary_10_3390_jcm13133876 crossref_primary_10_1038_s41591_021_01591_4 crossref_primary_10_1093_tbm_ibac086 crossref_primary_10_1136_bmjebm_2023_112338 crossref_primary_10_1128_mbio_02308_22 crossref_primary_10_1002_rmv_70009 crossref_primary_10_1016_j_ebiom_2022_104413 crossref_primary_10_3904_kjim_2022_050 crossref_primary_10_3389_fpubh_2024_1355973 crossref_primary_10_1016_j_euroneuro_2022_04_004 crossref_primary_10_1093_nar_gkac1005 crossref_primary_10_3390_ijerph19159076 crossref_primary_10_3390_jcm13175310 crossref_primary_10_62347_TXVO6284 crossref_primary_10_1111_nmo_14878 crossref_primary_10_1007_s11886_022_01793_3 crossref_primary_10_3390_brainsci14060604 crossref_primary_10_47102_annals_acadmedsg_V52N10p522 crossref_primary_10_1017_S1092852924002153 crossref_primary_10_1210_endrev_bnad032 crossref_primary_10_3390_jcm11092376 crossref_primary_10_1038_d41586_022_01341_7 crossref_primary_10_1016_j_cmi_2022_08_028 crossref_primary_10_1016_j_immuni_2022_09_006 crossref_primary_10_7189_jogh_15_04006 crossref_primary_10_1007_s12016_023_08962_4 crossref_primary_10_1016_j_ctim_2022_102823 crossref_primary_10_1080_21645515_2022_2036069 crossref_primary_10_1093_jamiaopen_ooad035 crossref_primary_10_1007_s43999_023_00020_y crossref_primary_10_1212_WNL_0000000000209248 crossref_primary_10_1007_s12031_023_02109_y crossref_primary_10_3390_ijerph191610450 crossref_primary_10_3947_ic_2022_0141 crossref_primary_10_3390_diagnostics14030244 crossref_primary_10_1111_jocn_16733 crossref_primary_10_1007_s40122_023_00486_1 crossref_primary_10_1016_j_jpsychores_2024_111598 crossref_primary_10_3390_ijerph20176678 crossref_primary_10_3390_vaccines10050652 crossref_primary_10_3389_fpsyt_2024_1337888 crossref_primary_10_3390_diagnostics12051162 crossref_primary_10_1016_j_ebiom_2024_105191 crossref_primary_10_1080_01635581_2022_2135745 crossref_primary_10_1080_23279095_2022_2123739 crossref_primary_10_1111_tid_14167 crossref_primary_10_1093_infdis_jiac281 crossref_primary_10_1016_j_cger_2022_04_003 crossref_primary_10_1192_j_eurpsy_2022_2317 crossref_primary_10_1038_s41598_022_17463_x crossref_primary_10_1097_01_TPM_0000902752_53691_86 crossref_primary_10_1136_bmj_2022_074572 crossref_primary_10_1097_MD_0000000000035666 crossref_primary_10_1371_journal_pone_0279408 crossref_primary_10_2147_IJGM_S453247 crossref_primary_10_1093_infdis_jiac136 crossref_primary_10_1001_jamapsychiatry_2024_2339 crossref_primary_10_3389_fnagi_2022_994331 crossref_primary_10_1016_j_jad_2024_05_134 crossref_primary_10_4103_aam_aam_199_23 crossref_primary_10_1186_s12879_024_09267_3 crossref_primary_10_1109_ACCESS_2024_3456246 crossref_primary_10_3390_v15081625 crossref_primary_10_3390_v14081755 crossref_primary_10_21518_ms2024_062 crossref_primary_10_1038_s41380_022_01545_3 crossref_primary_10_1136_bmj_2022_071050 crossref_primary_10_1177_1357633X241303804 crossref_primary_10_15406_ipmrj_2023_08_00324 crossref_primary_10_2139_ssrn_4048831 crossref_primary_10_1080_24745332_2022_2156407 crossref_primary_10_1002_brb3_2849 crossref_primary_10_1016_j_isci_2022_104833 crossref_primary_10_1038_s41440_022_01145_2 crossref_primary_10_1016_j_vhri_2023_09_005 crossref_primary_10_1186_s40001_023_01293_2 crossref_primary_10_3389_fpsyt_2025_1467876 crossref_primary_10_1016_j_chest_2024_01_029 crossref_primary_10_1016_j_ijid_2022_12_036 crossref_primary_10_26442_00403660_2023_01_202065 crossref_primary_10_3390_jcm12123966 crossref_primary_10_31083_j_rcm2302053 crossref_primary_10_1016_j_jbi_2022_104237 crossref_primary_10_1186_s12889_024_19264_5 crossref_primary_10_1152_ajpheart_00018_2023 crossref_primary_10_1007_s11739_023_03259_y crossref_primary_10_1038_s41598_023_48594_4 crossref_primary_10_1093_cid_ciae632 crossref_primary_10_30773_pi_2024_0159 crossref_primary_10_1111_joim_13587 crossref_primary_10_1016_j_psychres_2023_115166 crossref_primary_10_1080_14473828_2022_2076460 crossref_primary_10_1111_bjh_18010 crossref_primary_10_1111_joim_13584 crossref_primary_10_1093_braincomms_fcac206 crossref_primary_10_1161_CIRCULATIONAHA_122_059231 crossref_primary_10_1016_j_scib_2022_06_025 crossref_primary_10_3390_v16081256 crossref_primary_10_1016_j_heliyon_2024_e26130 crossref_primary_10_36106_ijar_5807089 crossref_primary_10_1038_s41591_022_01810_6 crossref_primary_10_3390_healthcare11081095 crossref_primary_10_1136_bmjopen_2024_092824 crossref_primary_10_1016_j_fmc_2022_02_015 crossref_primary_10_1038_s41598_025_88405_6 crossref_primary_10_1177_17562848221118403 crossref_primary_10_5507_bp_2022_039 crossref_primary_10_4187_respcare_10928 crossref_primary_10_1002_jmv_28750 crossref_primary_10_1021_acs_jproteome_3c00324 crossref_primary_10_3390_life14091076 crossref_primary_10_1016_j_bbi_2022_04_013 crossref_primary_10_1136_bmjopen_2022_069217 crossref_primary_10_3390_antiox12020393 crossref_primary_10_3390_life15030439 crossref_primary_10_1007_s00103_024_03967_6 crossref_primary_10_3389_fneur_2023_1221266 crossref_primary_10_21518_ms2024_150 crossref_primary_10_1016_j_crm_2022_100395 crossref_primary_10_1016_j_nbd_2023_106147 crossref_primary_10_1042_BCJ20220154 crossref_primary_10_1016_j_immuni_2024_05_010 crossref_primary_10_12688_hrbopenres_13503_1 crossref_primary_10_26565_2313_6693_2021_43_07 crossref_primary_10_5812_semj_133177 crossref_primary_10_1093_pubmed_fdad276 crossref_primary_10_1093_ofid_ofac679 crossref_primary_10_1073_pnas_2213524119 crossref_primary_10_1002_jmv_28524 crossref_primary_10_2196_47079 crossref_primary_10_1007_s00428_024_03771_2 crossref_primary_10_35339_ic_11_3_kov crossref_primary_10_1186_s12879_023_08801_z crossref_primary_10_1186_s12888_023_05481_6 crossref_primary_10_5125_jkaoms_2022_48_3_131 crossref_primary_10_1177_01410768231154703 crossref_primary_10_1371_journal_pgph_0004204 crossref_primary_10_3389_fnut_2022_1034169 crossref_primary_10_1016_j_bbih_2023_100587 crossref_primary_10_7759_cureus_80597 crossref_primary_10_22159_ijcpr_2023v15i6_4000 crossref_primary_10_1007_s11136_024_03719_8 crossref_primary_10_2196_32713 crossref_primary_10_3390_covid5010006 crossref_primary_10_1111_jsr_13542 crossref_primary_10_1016_j_psychres_2022_114931 crossref_primary_10_1371_journal_pone_0284075 crossref_primary_10_59564_AMRJ_01_01_007 crossref_primary_10_1007_s00415_024_12212_8 crossref_primary_10_1016_S2215_0366_22_00302_9 crossref_primary_10_3390_ijms23179739 crossref_primary_10_23736_S0022_4707_24_15516_8 crossref_primary_10_1016_j_amjcard_2024_05_037 crossref_primary_10_1016_j_ssmqr_2022_100177 crossref_primary_10_3389_fepid_2023_1193369 crossref_primary_10_1186_s10020_022_00528_y crossref_primary_10_5964_ejop_10097 crossref_primary_10_1186_s12979_022_00284_x crossref_primary_10_3390_biomedicines9111540 crossref_primary_10_1038_s41467_023_36223_7 crossref_primary_10_1097_RTI_0000000000000748 crossref_primary_10_1093_cid_ciac655 crossref_primary_10_1136_bmjopen_2023_072726 crossref_primary_10_1016_j_ehb_2022_101198 crossref_primary_10_1186_s12916_025_03881_x crossref_primary_10_1016_j_antiviral_2024_105958 crossref_primary_10_1093_ofid_ofad233 crossref_primary_10_1177_10738584231194927 crossref_primary_10_36740_WLek202208113 crossref_primary_10_1183_23120541_00355_2022 crossref_primary_10_3390_ijerph19105973 crossref_primary_10_1002_jgh3_12811 crossref_primary_10_1016_S2215_0366_22_00260_7 crossref_primary_10_1093_brain_awad008 crossref_primary_10_1177_21501319221114259 crossref_primary_10_2217_fmb_2022_0031 crossref_primary_10_3390_ijerph19116618 crossref_primary_10_3390_jcm12051931 crossref_primary_10_1016_j_ensci_2022_100418 crossref_primary_10_22159_ajpcr_2022_v15i12_44515 crossref_primary_10_1371_journal_ppat_1011063 crossref_primary_10_3389_fimmu_2022_1020064 crossref_primary_10_1111_cen_14816 crossref_primary_10_3389_fmed_2023_1219222 crossref_primary_10_1038_s41591_022_02051_3 crossref_primary_10_1111_pcn_13481 crossref_primary_10_1371_journal_pone_0273364 crossref_primary_10_3201_eid2903_221522 crossref_primary_10_1089_acu_2021_0086 crossref_primary_10_1371_journal_pone_0295177 crossref_primary_10_3390_brainsci13121670 crossref_primary_10_1007_s00702_024_02749_3 crossref_primary_10_1038_s41392_022_00986_0 crossref_primary_10_1016_j_iref_2023_07_010 crossref_primary_10_1016_j_jchromb_2023_123802 crossref_primary_10_3233_JAD_230626 crossref_primary_10_3389_fcvm_2024_1366269 crossref_primary_10_3390_nu15204474 crossref_primary_10_47102_annals_acadmedsg_2023238 crossref_primary_10_3390_vaccines10060849 crossref_primary_10_1016_j_bbi_2023_05_014 crossref_primary_10_1016_j_patter_2022_100659 crossref_primary_10_1016_j_lansea_2022_100129 crossref_primary_10_3390_cells11233882 crossref_primary_10_3389_fimmu_2024_1264702 crossref_primary_10_3389_fpubh_2025_1533315 crossref_primary_10_1177_11795735231195693 crossref_primary_10_1016_j_bbih_2025_100983 crossref_primary_10_1016_j_jpain_2022_06_010 crossref_primary_10_1038_s41467_022_31897_x crossref_primary_10_1016_j_jpain_2024_104579 crossref_primary_10_1007_s13311_022_01267_y crossref_primary_10_1016_j_ebiom_2022_104245 crossref_primary_10_1038_s41467_023_39193_y crossref_primary_10_4103_ajim_ajim_27_22 crossref_primary_10_3389_fneur_2024_1406475 crossref_primary_10_1093_ofid_ofad320 crossref_primary_10_1212_NXI_0000000000001151 crossref_primary_10_1186_s41687_022_00473_8 crossref_primary_10_1186_s12879_023_08947_w crossref_primary_10_1038_s41591_024_02987_8 crossref_primary_10_1590_1983_1447_2024_20230283_en crossref_primary_10_1016_j_eclinm_2024_102590 crossref_primary_10_1002_jmv_28214 crossref_primary_10_1007_s11914_022_00734_x crossref_primary_10_1016_j_jpsychores_2024_111602 crossref_primary_10_1097_WCO_0000000000001049 crossref_primary_10_1136_bmj_2022_070230 crossref_primary_10_1177_10556656231187302 crossref_primary_10_1136_bmjph_2023_000102 crossref_primary_10_1093_arclin_acad038 crossref_primary_10_2340_jrm_v54_3415 crossref_primary_10_7189_jogh_13_06020 crossref_primary_10_1002_ejp_2094 crossref_primary_10_1001_jamapsychiatry_2022_1616 crossref_primary_10_1097_01_HC9_0000897224_68874_de crossref_primary_10_3390_jcm13237124 crossref_primary_10_2196_34067 crossref_primary_10_1093_sleep_zsad126 crossref_primary_10_1016_j_jpsychores_2025_112091 crossref_primary_10_1136_bmjresp_2021_001041 crossref_primary_10_29254_2077_4214_2022_1_163_33_38 crossref_primary_10_3390_v14092000 crossref_primary_10_1186_s13030_022_00250_5 crossref_primary_10_3390_diagnostics13050882 crossref_primary_10_1097_HCR_0000000000000701 crossref_primary_10_1016_j_arr_2022_101686 crossref_primary_10_1007_s12297_022_00526_3 crossref_primary_10_1016_j_heliyon_2023_e19605 crossref_primary_10_1186_s12889_023_16252_z crossref_primary_10_1016_j_cell_2024_07_054 crossref_primary_10_1136_bmjopen_2022_060826 crossref_primary_10_1136_gpsych_2022_100802 crossref_primary_10_3389_fmed_2022_879971 crossref_primary_10_1186_s12879_024_09076_8 crossref_primary_10_3389_fnhum_2024_1409250 crossref_primary_10_3389_fnut_2023_1122203 crossref_primary_10_1016_S2215_0366_22_00307_8 crossref_primary_10_3389_frans_2022_846102 crossref_primary_10_1038_s41598_023_32636_y crossref_primary_10_2174_26669587_v2_e2209160 crossref_primary_10_1136_bmjopen_2022_065142 crossref_primary_10_1016_j_medj_2022_04_001 crossref_primary_10_1007_s11673_022_10182_y crossref_primary_10_3389_fimmu_2025_1515768 crossref_primary_10_3389_phrs_2022_1604434 crossref_primary_10_1001_jamainternmed_2023_0743 crossref_primary_10_2139_ssrn_4143696 crossref_primary_10_4103_jalh_jalh_11_22 crossref_primary_10_1183_16000617_0185_2021 crossref_primary_10_1016_j_bbih_2022_100455 crossref_primary_10_1038_s41598_024_75233_3 crossref_primary_10_1038_s41380_022_01615_6 crossref_primary_10_3390_microorganisms11092241 crossref_primary_10_1186_s12916_023_03216_8 crossref_primary_10_1016_j_conb_2022_102608 crossref_primary_10_1038_s41398_023_02575_3 crossref_primary_10_1186_s12916_023_03049_5 crossref_primary_10_1016_j_ijcrp_2024_200267 crossref_primary_10_1038_s41591_023_02521_2 crossref_primary_10_1093_cvr_cvac115 crossref_primary_10_3201_eid3003_231194 crossref_primary_10_4103_hm_hm_63_21 crossref_primary_10_4103_lungindia_lungindia_250_22 crossref_primary_10_1097_MJT_0000000000001744 crossref_primary_10_3389_fmed_2022_925703 crossref_primary_10_1016_j_bbih_2024_100805 crossref_primary_10_1016_j_lanepe_2023_100595 crossref_primary_10_1371_journal_pmed_1004511 crossref_primary_10_1080_21641846_2022_2124064 crossref_primary_10_1556_650_2024_33107 crossref_primary_10_1016_j_blre_2023_101075 crossref_primary_10_3389_fpsyt_2023_1138389 crossref_primary_10_3390_ijerph20043100 crossref_primary_10_1590_1806_9282_20231211 crossref_primary_10_1038_s41467_023_41541_x crossref_primary_10_1016_j_idnow_2023_104673 crossref_primary_10_22141_2224_0586_17_8_2021_245567 crossref_primary_10_1016_j_biopha_2023_114752 crossref_primary_10_1093_ofid_ofac397 crossref_primary_10_1007_s00406_024_01863_3 crossref_primary_10_1016_j_envres_2023_118066 crossref_primary_10_1038_s41380_023_02171_3 crossref_primary_10_14814_phy2_15636 crossref_primary_10_1016_j_ijbiomac_2022_01_118 crossref_primary_10_3389_fcvm_2023_1238034 crossref_primary_10_3390_biomedicines10082050 crossref_primary_10_3390_cells12050816 crossref_primary_10_1044_2022_JSLHR_22_00381 crossref_primary_10_3390_ijerph20105866 crossref_primary_10_1002_ana_26649 crossref_primary_10_1038_s41598_022_21289_y crossref_primary_10_1093_bmb_ldad016 crossref_primary_10_1038_s41586_022_05398_2 crossref_primary_10_3390_covid3110114 crossref_primary_10_1001_jamanetworkopen_2024_23555 crossref_primary_10_1016_j_ccm_2022_11_018 crossref_primary_10_1017_S0950268824000748 crossref_primary_10_1016_j_jinf_2024_106267 crossref_primary_10_1172_JCI161167 crossref_primary_10_1016_j_jaut_2024_103267 crossref_primary_10_1038_s41590_024_01754_8 crossref_primary_10_33920_med_10_2310_04 crossref_primary_10_1186_s12916_021_02222_y crossref_primary_10_1016_j_gtc_2022_09_002 crossref_primary_10_15829_15604071_2023_5582 crossref_primary_10_1016_j_actpsy_2023_103838 crossref_primary_10_3390_covid4070067 crossref_primary_10_3390_medicina61020344 crossref_primary_10_3390_v14030637 crossref_primary_10_1016_j_amjmed_2023_05_002 crossref_primary_10_3390_diagnostics14060631 crossref_primary_10_1002_acm2_13628 crossref_primary_10_1016_j_nsa_2023_103932 crossref_primary_10_15789_1563_0625_CAA_2849 crossref_primary_10_1007_s42399_022_01352_5 crossref_primary_10_22159_ijap_2023v15i6_48889 crossref_primary_10_1097_MNM_0000000000001689 crossref_primary_10_1002_pmrj_13098 crossref_primary_10_1186_s12889_022_12659_2 crossref_primary_10_1016_j_chest_2023_03_014 crossref_primary_10_3389_fmed_2024_1346888 crossref_primary_10_3390_jcm12124158 crossref_primary_10_1001_jamanetworkopen_2022_25657 crossref_primary_10_3389_fphar_2024_1384264 crossref_primary_10_3389_fneur_2022_846957 crossref_primary_10_1016_j_lfs_2024_122940 crossref_primary_10_3390_biom12010021 crossref_primary_10_1155_2023_3140708 crossref_primary_10_2139_ssrn_4100659 crossref_primary_10_1371_journal_pone_0295418 crossref_primary_10_1002_jmv_29928 crossref_primary_10_1016_j_heliyon_2024_e24053 crossref_primary_10_3389_fimmu_2022_848886 crossref_primary_10_1016_j_cytogfr_2022_02_002 crossref_primary_10_1136_bmjph_2023_000060 crossref_primary_10_1371_journal_pone_0318272 crossref_primary_10_1038_s41591_023_02525_y crossref_primary_10_1093_eurjpc_zwae098 crossref_primary_10_1093_ofid_ofad047 crossref_primary_10_1371_journal_ppat_1010591 crossref_primary_10_1159_000536352 crossref_primary_10_1097_HS9_0000000000000711 crossref_primary_10_3390_ijms23031583 crossref_primary_10_37349_emed_2023_00158 crossref_primary_10_3390_ijerph20075223 |
| Cites_doi | 10.1001/jama.2021.3331 10.1038/s41591-020-01177-6 10.1038/s41591-021-01283-z 10.1093/cid/ciaa248 10.1038/s41577-020-0311-8 10.1136/bmj.m3026 10.2307/1932409 10.1146/annurev-publhealth-032315-021353 10.1073/pnas.0400087101 10.1016/j.socscimed.2020.113426 10.1016/S2215-0366(20)30462-4 10.1038/s41586-020-2521-4 10.1136/bmj.m3871 10.1016/S0140-6736(20)32656-8 10.1136/bmj.n1098 10.1093/biomet/70.1.41 10.1002/sim.1203 10.1001/jama.2015.13480 10.1016/S0140-6736(20)32705-7 10.1136/bmj.n136 10.1016/S0140-6736(20)32662-3 10.1016/S2215-0366(21)00084-5 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2021 Public Library of Science 2021 Taquet et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2021 Taquet et al 2021 Taquet et al |
| Copyright_xml | – notice: COPYRIGHT 2021 Public Library of Science – notice: 2021 Taquet et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2021 Taquet et al 2021 Taquet et al |
| DBID | AAYXX CITATION IOV ISN ISR 3V. 7TK 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU COVID DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA CZK |
| DOI | 10.1371/journal.pmed.1003773 |
| DatabaseName | CrossRef Gale In Context: Opposing Viewpoints Gale In Context: Canada Gale In Context: Science ProQuest Central (Corporate) Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central (New) ProQuest One Community College Coronavirus Research Database ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection PML(ProQuest Medical Library) ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals PLoS Medicine |
| DatabaseTitle | CrossRef Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitleAlternate | Incidence, co-occurrence and evolution of long-COVID features |
| EISSN | 1549-1676 |
| ExternalDocumentID | 2582589576 oai_doaj_org_article_f5299df8a1174dd6840a98866f770fcc PMC8478214 A677985751 10_1371_journal_pmed_1003773 |
| GeographicLocations | United Kingdom United States--US |
| GeographicLocations_xml | – name: United Kingdom – name: United States--US |
| GrantInformation_xml | – fundername: ; grantid: Principal Research Fellowship 206330/Z/17/Z – fundername: ; grantid: Oxford Biomedical Research Centre – fundername: ; grantid: BRC-1215-20005 – fundername: ; grantid: Academic Clinical Fellowship |
| GroupedDBID | --- 123 29O 2WC 53G 5VS 7X7 88E 8FI 8FJ AAFWJ AAUCC AAWOE AAWTL AAYXX ABDBF ABUWG ACGFO ACIHN ACPRK ACUHS ADBBV AEAQA AENEX AFKRA AFPKN AFRAH AFXKF AHMBA AKRSQ ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS B0M BAWUL BCNDV BENPR BPHCQ BVXVI BWKFM CCPQU CITATION CS3 DIK DU5 E3Z EAP EAS EBD EBS EJD EMK EMOBN ESX F5P FPL FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR IHW INH INR IOF IOV IPO ISN ISR ITC KQ8 M1P M48 MK0 O5R O5S OK1 OVT P2P PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PV9 RNS RPM RZL SV3 TR2 TUS UKHRP WOW XSB YZZ ~8M PMFND 3V. 7TK 7XB 8FK AZQEC COVID DWQXO K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 5PM PUEGO - AAPBV ABPTK ADACO BBAFP BCGST CZK ICW M~E |
| ID | FETCH-LOGICAL-c807t-79b28e1b2e54dbbe5fdbba2a9ecd3a61105fcce62571fbb7105ccc0e1e1767ce3 |
| IEDL.DBID | M48 |
| ISSN | 1549-1676 1549-1277 |
| IngestDate | Fri Nov 26 17:11:50 EST 2021 Wed Aug 27 01:21:25 EDT 2025 Thu Aug 21 13:49:18 EDT 2025 Fri Jul 11 03:38:56 EDT 2025 Fri Jul 25 23:01:57 EDT 2025 Tue Jun 17 21:10:58 EDT 2025 Thu Jun 12 23:33:01 EDT 2025 Tue Jun 10 20:42:25 EDT 2025 Fri Jun 27 05:08:59 EDT 2025 Fri Jun 27 03:58:01 EDT 2025 Fri Jun 27 03:54:32 EDT 2025 Thu May 22 21:15:45 EDT 2025 Tue Jul 01 03:27:46 EDT 2025 Thu Apr 24 22:49:08 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 9 |
| Language | English |
| License | This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Creative Commons Attribution License |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c807t-79b28e1b2e54dbbe5fdbba2a9ecd3a61105fcce62571fbb7105ccc0e1e1767ce3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 I have read the journal’s policy and the authors of this manuscript have the following competing interests: SL is an employee of TriNetX Inc. The other authors report no interests to declare. |
| ORCID | 0000-0001-8264-347X 0000-0002-6850-9255 0000-0002-8987-952X |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.pmed.1003773 |
| PMID | 34582441 |
| PQID | 2582589576 |
| PQPubID | 1436338 |
| ParticipantIDs | plos_journals_2582589576 doaj_primary_oai_doaj_org_article_f5299df8a1174dd6840a98866f770fcc pubmedcentral_primary_oai_pubmedcentral_nih_gov_8478214 proquest_miscellaneous_2577730442 proquest_journals_2582589576 gale_infotracmisc_A677985751 gale_infotracgeneralonefile_A677985751 gale_infotracacademiconefile_A677985751 gale_incontextgauss_ISR_A677985751 gale_incontextgauss_ISN_A677985751 gale_incontextgauss_IOV_A677985751 gale_healthsolutions_A677985751 crossref_citationtrail_10_1371_journal_pmed_1003773 crossref_primary_10_1371_journal_pmed_1003773 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 20210928 |
| PublicationDateYYYYMMDD | 2021-09-28 |
| PublicationDate_xml | – month: 9 year: 2021 text: 20210928 day: 28 |
| PublicationDecade | 2020 |
| PublicationPlace | San Francisco |
| PublicationPlace_xml | – name: San Francisco – name: San Francisco, CA USA |
| PublicationTitle | PLoS medicine |
| PublicationYear | 2021 |
| Publisher | Public Library of Science Public Library of Science (PLoS) |
| Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
| References | A Barrat (pmed.1003773.ref023) 2004 M Dani (pmed.1003773.ref028) 2021 A Hampshire (pmed.1003773.ref025) 2021; 23 C Huang (pmed.1003773.ref012) 2021; 397 PR Rosenbaum (pmed.1003773.ref019) 1983; 70 MZ Tay (pmed.1003773.ref027) 2020; 20 Writing Committee for the COMEBAC Study Group (pmed.1003773.ref010) 2021; 325 M Taquet (pmed.1003773.ref015) 2021; 8 S de Lusignan (pmed.1003773.ref016) 2020 (pmed.1003773.ref003) 2020; 26 M Butler (pmed.1003773.ref006) 2020; 371 T Greenhalgh (pmed.1003773.ref007) 2020 E Ladds (pmed.1003773.ref031) 2020 EJ Williamson (pmed.1003773.ref017) 2020; 584 JA Casey (pmed.1003773.ref026) 2016; 37 (pmed.1003773.ref002) 2020; 396 LR Dice (pmed.1003773.ref022) 1945; 26 A Nalbandian (pmed.1003773.ref004) 2021; 27 P Royston (pmed.1003773.ref021) 2002 W Shah (pmed.1003773.ref030) 2021; 372 C Qin (pmed.1003773.ref024) 2020; 71 Z Al-Aly (pmed.1003773.ref014) 2021 F Callard (pmed.1003773.ref001) 2021; 268 JS Haukoos (pmed.1003773.ref020) 2015; 314 C Del Rio (pmed.1003773.ref005) 2020 R Gorna (pmed.1003773.ref008) 2021; 397 CH Sudre (pmed.1003773.ref011) 2021 SE Daugherty (pmed.1003773.ref018) 2021; 373 DM Altmann (pmed.1003773.ref029) 2021 M Taquet (pmed.1003773.ref013) 2021; 8 HE Davis (pmed.1003773.ref009) 2021 |
| References_xml | – volume: 325 start-page: 1525 year: 2021 ident: pmed.1003773.ref010 article-title: Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19 publication-title: JAMA doi: 10.1001/jama.2021.3331 – year: 2021 ident: pmed.1003773.ref009 article-title: Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact publication-title: EClinicalMedicine – volume: 26 start-page: 1803 year: 2020 ident: pmed.1003773.ref003 article-title: Meeting the challenge of long COVID publication-title: Nat Med doi: 10.1038/s41591-020-01177-6 – year: 2020 ident: pmed.1003773.ref031 article-title: Persistent symptoms after Covid-19: qualitative study of 114 “long Covid” patients and draft quality principles for services publication-title: BMC Health Serv Res – year: 2020 ident: pmed.1003773.ref005 article-title: Long-term Health Consequences of COVID-19 publication-title: JAMA – volume: 27 start-page: 601 year: 2021 ident: pmed.1003773.ref004 article-title: Post-acute COVID-19 syndrome publication-title: Nat Med doi: 10.1038/s41591-021-01283-z – year: 2021 ident: pmed.1003773.ref011 article-title: Attributes and predictors of long COVID publication-title: Nat Med – volume: 71 start-page: 762 year: 2020 ident: pmed.1003773.ref024 article-title: Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan China publication-title: Clin Infect Dis doi: 10.1093/cid/ciaa248 – volume: 20 start-page: 363 year: 2020 ident: pmed.1003773.ref027 article-title: The trinity of COVID-19: immunity, inflammation and intervention publication-title: Nat Rev Immunol doi: 10.1038/s41577-020-0311-8 – start-page: m3026 year: 2020 ident: pmed.1003773.ref007 article-title: Management of post-acute covid-19 in primary care publication-title: BMJ doi: 10.1136/bmj.m3026 – volume: 26 start-page: 297 year: 1945 ident: pmed.1003773.ref022 article-title: Measures of the amount of ecologic association between species publication-title: Ecology doi: 10.2307/1932409 – volume: 37 start-page: 61 year: 2016 ident: pmed.1003773.ref026 article-title: Using Electronic Health Records for Population Health Research: A Review of Methods and Applications publication-title: Annu Rev Public Health doi: 10.1146/annurev-publhealth-032315-021353 – year: 2021 ident: pmed.1003773.ref028 article-title: Autonomic dysfunction in “long COVID”: rationale, physiology and management strategies publication-title: Clin Dermatol – start-page: 3747 year: 2004 ident: pmed.1003773.ref023 article-title: The architecture of complex weighted networks publication-title: Proc Natl Acad Sci doi: 10.1073/pnas.0400087101 – volume: 268 start-page: 113426 year: 2021 ident: pmed.1003773.ref001 article-title: How and why patients made Long Covid publication-title: Soc Sci Med doi: 10.1016/j.socscimed.2020.113426 – year: 2021 ident: pmed.1003773.ref014 article-title: High-dimensional characterization of post-acute sequalae of COVID-19 publication-title: Nature – volume: 8 start-page: 130 year: 2021 ident: pmed.1003773.ref015 article-title: Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA publication-title: Lancet Psychiatry doi: 10.1016/S2215-0366(20)30462-4 – volume: 584 start-page: 430 year: 2020 ident: pmed.1003773.ref017 article-title: Factors associated with COVID-19-related death using OpenSAFELY publication-title: Nature doi: 10.1038/s41586-020-2521-4 – volume: 371 start-page: m3871 year: 2020 ident: pmed.1003773.ref006 article-title: Neuropsychiatric complications of covid-19 publication-title: BMJ doi: 10.1136/bmj.m3871 – year: 2020 ident: pmed.1003773.ref016 article-title: Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study publication-title: Lancet Infect Dis – volume: 397 start-page: 220 year: 2021 ident: pmed.1003773.ref012 article-title: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study publication-title: Lancet doi: 10.1016/S0140-6736(20)32656-8 – year: 2021 ident: pmed.1003773.ref029 article-title: Decoding the unknowns in long covid publication-title: BMJ – volume: 373 start-page: n1098 year: 2021 ident: pmed.1003773.ref018 article-title: Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study publication-title: BMJ doi: 10.1136/bmj.n1098 – volume: 70 start-page: 41 year: 1983 ident: pmed.1003773.ref019 article-title: The central role of the propensity score in observational studies for causal effects publication-title: Biometrika doi: 10.1093/biomet/70.1.41 – start-page: 2175 year: 2002 ident: pmed.1003773.ref021 article-title: Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects publication-title: Stat Med doi: 10.1002/sim.1203 – volume: 314 start-page: 1637 year: 2015 ident: pmed.1003773.ref020 article-title: The propensity score publication-title: JAMA doi: 10.1001/jama.2015.13480 – volume: 23 start-page: 101044 year: 2021 ident: pmed.1003773.ref025 article-title: Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine publication-title: Jul – volume: 397 start-page: 455 year: 2021 ident: pmed.1003773.ref008 article-title: Long COVID guidelines need to reflect lived experience publication-title: Lancet doi: 10.1016/S0140-6736(20)32705-7 – volume: 372 start-page: n136 year: 2021 ident: pmed.1003773.ref030 article-title: Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline publication-title: BMJ doi: 10.1136/bmj.n136 – volume: 396 start-page: 1861 year: 2020 ident: pmed.1003773.ref002 article-title: The Lancet. Facing up to long COVID publication-title: Lancet doi: 10.1016/S0140-6736(20)32662-3 – volume: 8 start-page: 416 year: 2021 ident: pmed.1003773.ref013 article-title: 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records publication-title: Lancet Psychiatry doi: 10.1016/S2215-0366(21)00084-5 |
| SSID | ssj0029090 |
| Score | 2.726265 |
| Snippet | Background Long-COVID refers to a variety of symptoms affecting different organs reported by people following Coronavirus Disease 2019 (COVID-19) infection. To... Long-COVID refers to a variety of symptoms affecting different organs reported by people following Coronavirus Disease 2019 (COVID-19) infection. To date,... Maxime Taquet and colleagues investigate the incidence, co-occurrence and evolution of long-COVID features in more than a quarter of a million people. BackgroundLong-COVID refers to a variety of symptoms affecting different organs reported by people following Coronavirus Disease 2019 (COVID-19) infection. To... Background Long-COVID refers to a variety of symptoms affecting different organs reported by people following Coronavirus Disease 2019 (COVID-19) infection. To... |
| SourceID | plos doaj pubmedcentral proquest gale crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database |
| StartPage | e1003773 |
| SubjectTerms | Abdomen Age Anxieties Anxiety Atopic dermatitis Cardiovascular disease Chest Codes Cognitive ability Cohort analysis Computer and Information Sciences Coronaviruses COVID-19 Dementia Demography Electronic health records Electronic medical records Ethnicity Fatigue Headache Headaches Illnesses Influenza Long COVID Medicine and Health Sciences Mental depression Myalgia Pain Patients Risk factors |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3da9swEBejD2MvY580a7dpY2wv1WrJlmXvLetW2kFb2NbSNyPrIx0EO8RO_4P937uTlVBDoX0YhECsn024O53urNPvCPkAmY4uyzpjXsuEZZmHKZVzx2RqXS5s7m04lXZymh-dZz8u5eWNVl9YEzbQAw-C2_cSHKb1heYQO1uL3CS6LIo890ol3hj0vrDmrZOpmGqVSXi7gvxjjAul4qG5VPH9qKPPC1htsEYgVSodLUqBu3_jobcW87YbhZ_j4skbq9HhE_I4hpF0Ovz9p-SBa56Rhydxo_w5-QvzfmgXukdNy1pjAg8T_tSNpe46WhxtPZ23zYwdnF0cf6PeBZ7P7gud0pyBhfZXdOn6Zbs-kEmxoe6yp4GVFm-GuGQv5wXtVuBzrttlhxfDwxgvX5Dzw--_D45Y7LjATJGonqmyFoXjtXAys3XtpIdvLXTpjE11DqGCBJGDEqXivq4hOpHGmMRxx1WujEtfkq2mbdw2oTZVUlpRqwRzSF2UmXaZENYKWyvhsglJ1yKvTKQjx64Y8yrssSlISwZRVqioKipqQtjmrsVAx3EH_itqc4NFMu1wAUysiiZW3WViE_IWbaEaTqZuXEI1zZUqscMpn5D3AYGEGg1W7Mz0quuq47OLe4B-nd4H9HME-hRBvgWZGR2PUoDkkc1rhPw4Qs4GLvPbgLsjIDgZMxrexnmwlnFXCVnAp4RsFe5cz43bh99thvGhWNPXuHaFGAUaSrJMTIgazamRusYjzZ-rwIEOQVUhePbqf-h3hzwSWKmEe43FLtnqlyv3GkLNvn4TvMo_LXV67Q priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELegSIgXxKfWMcAgBC8zi504TnhBZTBtSNskYFPfIscfHVIVl6Tdf8D_jc9xOyJNsJdKjX9OFF_ufGeff4fQGx_pyLKsM2IlT0iWWa9SOTWEp9rkTOdWh1Npxyf54Vn2dcqnccGti2mVa5sYDLV2CtbI9xj3sUxRevf44-IXgapRsLsaS2jcRneAugxSusT0KuAqk7DGAixkhDIh4tG5VNC9KKn3Cz_nQKZAKkQ6mJoCg__GTo8Wc9cNnNBhCuVfc9LBA3Q_OpN40kv_Ibplmkfo7nHcLn-Mfnvt74uG7mLliFMqsDHBX9lobC7jd4edxXPXzMj-6fnRZ2xNYPvsPuAJzol_8eUFbs2ydetjmRjK6rZLHLhpobP3TnZzWuBu5S3PpWs7uBhuRmj5BJ0dfPmxf0hi3QWiikQsiShrVhhaM8MzXdeGW_8rmSyN0qnMvcPArVJelFxQW9feR-FKqcRQQ0UulEmfolHjGrOFsE4F55rVIoFIUhZlJk3GmNZM14KZbIzS9ZBXKpKSQ22MeRV22oQPTvqhrEBQVRTUGJFNr0VPyvEf_CeQ5gYLlNrhgmtnVdTQynI_M2tbSOqDNK2BBEeWRZHnVojEv-8YvYRvoerPp24MQzXJhSihzikdo9cBAbQaDeTtzOSq66qj0_MbgL6f3AT0bQB6F0HW-TFTMh6o8CMPnF4D5NsBctYzml8H3BkAvalRg-Yt0IP1GHfVlVL6nmvduL751aYZbgqZfY1xK8AIL6Eky9gYiYFODcQ1bGl-XgQmdO9aFYxm2_9--DN0j0EmEuwlFjtotGxX5rl3JZf1i2Av_gC203Kc priority: 102 providerName: ProQuest |
| Title | Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19 |
| URI | https://www.proquest.com/docview/2582589576 https://www.proquest.com/docview/2577730442 https://pubmed.ncbi.nlm.nih.gov/PMC8478214 https://doaj.org/article/f5299df8a1174dd6840a98866f770fcc http://dx.doi.org/10.1371/journal.pmed.1003773 |
| Volume | 18 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1ta9swEBZtCmNfxl5pui7Txti-1MWWX2QPxki7lnYj6datJd-MLMnpINiZ7ZTtB-x_705-YYaMBYIh1iOD73SnO0t6jpBXkOmIKEo8KxW-bXleCiYVONryXaUDpoJUmVNpk2lwduV9nPmzLdLWbG0EWK5N7bCe1FWxOPz549d7MPh3pmoDd9pOh0uYP3DV3-Xc3SY7MDdxNNWJ160rsMg2X12Ql8xyGOfNYbp_PaU3WRlO_85zD5aLvOyFpf1NlX_NUqf3yb0mvKTjejw8IFs6e0juTJoF9EfkN_iDuozoAZW5lUtp-Jnwr8gU1bfNSKR5Shd5NreOL67PP9BUG_7P8i0d08CCkVvd0EJXRd4e1KRYaLeoqGGrxc4QrxwETkjLFfii27wo8aZ5mOVEj8nV6cm34zOrqcRgydDmlcWjhIXaSZj2PZUk2k_hKpiItFSuCCCE8FMpQbk-d9IkgajFl1La2tEOD7jU7hMyyPJM7xKqXO77iiXcxtxShJEntMeYUkwlnGlvSNxW5LFsaMqxWsYiNmtvHNKVWpQxKipuFDUkVtdrWdN0_Ad_hNrssEiybW7kxTxubDZOfZirVRoKB9I2pZAWR0RhGAQp5za875A8x7EQ1ydWO1cRjwPOI6x86gzJS4NAoo0Md_LMxaos4_OL6w1AX6ebgC57oDcNKM1BZlI0RyxA8sjy1UO-7iHnNcf5OuB-DwjOR_aad9EOWhmXMfND-EWQxULP1jbWN7_omvGhuNcv0_kKMRw0ZHseGxLes6meuvot2fcbw40OwVbIHG9vE3E9JXcZ7lDCNcZwnwyqYqWfQYhZJSOyzWd8RHaOTqafL0fmQw1cP30JR8af_AGbFX7B |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zb9NAEF6VVAJeEKcaKHRBHC9daq-PtZEQSi81tElRaau-GXt3nSJFdrCdIn4Af4ffyIy9DliqoC99iRTvrJ3M7M7hnfmGkJcQ6cRhmLgsjT2LuW4KW8q3NfMcpX2u_FTVVWmjsb934n48886WyK-2FgbTKludWCtqlUt8R77BPYhlghDc4w-zbwy7RuHpattCo1kW-_rHdwjZyvfDbZDvK853d4639pjpKsBkYImKiTDhgbYTrj1XJYn2UviMeRxqqZzYB3PopVLCD_WEnSYJWGBPSmlpW9vCF1I7cN8bZNl1IJTpkeXNnfGno0WIF1r1Wx3EPWM2F8IU6znC3jBr4-0MrBzmJjhCOB1jWPcMWFiG3myalx23t5u0-ZcV3L1L7hj3lQ6a9XaPLOnsPrk5Mgf0D8hP0DdNm9J1KnOWS1njP-HXOFNUX5iVTvOUTvNswrYOT4fbNNU1vmj5jg6oz4DV1TktdFXkbSEoxUa-RUVrNFycDP7Qum8HtJyDrrvIixIv1jdjdviQnFyLTB6RXpZneoVQ5QjPUzwRFsaucRC6sXY5V4qrRHDt9onTsjySBgYdu3FMo_psT0A41LAyQkFFRlB9whazZg0MyH_oN1GaC1oE8a4v5MUkMjohSj3wBVQaxDaEhUoh7E4cBoHvp0JY8H_7ZA3XQtRUxC5UUTTwhQixs6rdJy9qCgTyyDBTaBLPyzIaHp5egejz-CpERx2iN4YozYFnMjYlHMB5RBHrUL7uUE4aDPXLCFc7hKDcZGd4BfdBy-My-qMGYGa7Ny4ffr4YxptiLmGm8znSCJCQ5bq8T0RnT3XE1R3Jvp7X2OvgzAXcdh__--Fr5Nbe8eggOhiO95-Q2xzzoPAkM1glvaqY66fgyFbJM6M9KPly3QrrN_sfs3U |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKkSouiKdYKNQgHpeaxk4cJ0gIlZaqS2mLgFa9hcSPLVKVLJvdIn4Af4pfx4yTbIlUQS-9rLTxONmd8bzi8TeEPIVMJ0_TImIulwGLIgcqFXPLZGhsLEzsjD-VtrsXbx9E74_k0QL53Z2FwbLKziZ6Q20qje_I14SEXCZJITxec21ZxMfNrTfj7ww7SOFOa9dOo1kiO_bnD0jf6tfDTZD1MyG23n3Z2GZthwGmk0BNmUoLkVheCCsjUxRWOvjMRZ5abcI8Btcondbwo6XirijAG0utdWC55SpW2oZw3yvkqgolRx1TR2fJXhr49zuIgMa4UKo9thcqvtaukpdj8HdYpRAqFfbcou8eMPcRi-OTqu4FwP3yzb_84dYNcr0NZOl6s_JukgVb3iJLu-1W_W3yCyxP07B0leqKVVp7JCj8mpeG2tN2zdPK0ZOqHLGN_cPhJnXWI43Wr-g6jRkwenpMJ3Y6qbojoRRb-k6m1OPi4mSIjFZjntB6BlbvtJrUeNHfjPH0Djm4FIncJYtlVdp7hJpQSWlEoQLMYvMkjXIbCWGMMIUSNhqQsGN5pltAdOzLcZL5XT4FiVHDygwFlbWCGhA2nzVuAEH-Q_8WpTmnRThvf6GajLLWOmROQlRgXJJzSBCNQQCePE2SOHZKBfB_B2QF10LWnI2dG6VsPVYqxR6rfECeeAqE9ChROUb5rK6z4f7hBYg-712E6FOP6EVL5Crgmc7bwxzAecQT61E-71GOGjT18wiXe4Rg5nRv-B7qQcfjOjszCDCz043zhx_Ph_GmWFVY2mqGNAokFESRGBDV06meuPoj5bdjj8IOYV0ieHT_3w9fIUtgprIPw72dB-SawIIo3NJMlsnidDKzDyGinRaPvOmg5Otl26o_Gfe2RQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Incidence%2C+co-occurrence%2C+and+evolution+of+long-COVID+features%3A+A+6-month+retrospective+cohort+study+of+273%2C618+survivors+of+COVID-19&rft.jtitle=PLoS+medicine&rft.au=Taquet%2C+Maxime&rft.au=Dercon%2C+Quentin&rft.au=Luciano%2C+Sierra&rft.au=Geddes%2C+John+R&rft.date=2021-09-28&rft.pub=Public+Library+of+Science&rft.issn=1549-1277&rft.volume=18&rft.issue=9&rft_id=info:doi/10.1371%2Fjournal.pmed.1003773&rft.externalDBID=ISR&rft.externalDocID=A677985751 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1549-1676&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1549-1676&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1549-1676&client=summon |